BRIEF-Grand Pharmaceutical Provides Update On Strategic Investment In Telix

Reuters
28 Feb
BRIEF-Grand Pharmaceutical Provides Update On Strategic Investment In Telix

Feb 28 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK:

  • UPDATE ON STRATEGIC INVESTMENT IN TELIX

  • DEAL FOR AU$143 MILLION.

  • DISPOSED 45.2% OF ITS HOLDIN IN TELIX PHARMACEUTICALS

  • INTENTION NOT TO SELL REMAINING TELIX SHARES WITHIN NEXT 12 MONTHS

Further company coverage: 0512.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10